Lonza to Develop, Manufacture U.S. Biopharma Firm’s Antibody Drug Conjugate
06:01 AM | September 27, 2012 | Deepti Ramesh
Lonza says that biopharmaceutical company Intellect Neurosciences (New York) has awarded the future development and manufacture of the antibody-drug conjugate Conjumab-A to Lonza, subject to...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.